We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+15.79%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$48.8B
AUM Growth
+$4.38B
(+9.9%)
Cap. Flow
-$540M
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
19.02%
Holding
2,611
New
251
Increased
862
Reduced
1,166
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$479M |
| 2 |
Costco
COST
|
+$402M |
| 3 |
Netflix
NFLX
|
+$355M |
| 4 |
Nike
NKE
|
+$321M |
| 5 |
Atlassian
TEAM
|
+$312M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$768M |
| 2 |
Cisco
CSCO
|
+$334M |
| 3 |
Amgen
AMGN
|
+$283M |
| 4 |
Fortinet
FTNT
|
+$267M |
| 5 |
DoorDash
DASH
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Financials | 15.2% |
| 3 | Healthcare | 13.93% |
| 4 | Consumer Discretionary | 13.71% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
GSI Technology
GSIT
$216M
| $34.6K | ﹤0.01% |
10,300
-21,200
| -67% | -$64.6K |
|
|
NOTV
2277
DELISTED
Inotiv
NOTV
| $31.1K | ﹤0.01% |
17,100
-2,800
| -14% | -$6.07K |
|
2278
Pacific Biosciences
PACB
$422M
| $31K | ﹤0.01% |
25,000
-77,500
| -76% | -$89.5K |
|
2279
Clear Channel Outdoor Holdings
CCO
$1.23B
| $30.9K | ﹤0.01% |
26,415
-30,685
| -54% | -$33.1K |
|
2280
Accuray
ARAY
$28.4M
| $30.3K | ﹤0.01% |
22,100
-28,713
| -57% | -$42.5K |
|
2281
Ampco-Pittsburgh
AP
$167M
| $30.2K | ﹤0.01% |
10,200
-600
| -6% | -$1.56K |
|
2282
Rallybio
RLYB
$86.6M
| $30K | ﹤0.01% |
11,113
-265
| -2% | -$702 |
|
|
HIVE
2283
HIVE Digital Technologies
HIVE
$792M
| $29.3K | ﹤0.01% |
16,300
-23,800
| -59% | -$41.9K |
|
2284
Atossa Therapeutics
ATOS
$22.8M
| $28.4K | ﹤0.01% |
2,280
-1,513
| -40% | -$18.1K |
|
2285
GEE Group
JOB
$23.4M
| $27.3K | ﹤0.01% |
138,900
-50,300
| -27% | -$9.64K |
|
2286
Greenland Technologies Holding
GTEC
$13.6M
| $24.9K | ﹤0.01% |
+12,500
| New | +$24K |
|
2287
SmartRent
SMRT
$183M
| $23.7K | ﹤0.01% |
+23,900
| New | +$21.4K |
|
|
ADVM
2288
DELISTED
Adverum Biotechnologies
ADVM
| $23K | ﹤0.01% |
+10,681
| New | +$29.9K |
|
2289
Harvard Bioscience
HBIO
$27.1M
| $20.8K | ﹤0.01% |
4,685
-8,871
| -65% | -$37.1K |
|
|
USAS
2290
Americas Gold and Silver
USAS
$1.34B
| $20.4K | ﹤0.01% |
+10,120
| New | +$16.3K |
|
|
RJET
2291
Republic Airways Holdings
RJET
$810M
| $15.8K | ﹤0.01% |
1,133
-234
| -17% | -$3.55K |
|
2292
Relmada Therapeutics
RLMD
$544M
| $15.1K | ﹤0.01% |
25,100
-262,900
| -91% | -$135K |
|
2293
Lineage Cell Therapeutics
LCTX
$257M
| $13.2K | ﹤0.01% |
14,500
-208,864
| -94% | -$124K |
|
|
CYPH
2294
Cypherpunk Technologies Inc
CYPH
$66.2M
| $12.3K | ﹤0.01% |
+41,280
| New | +$15K |
|
2295
Ring Energy
REI
$322M
| $11.4K | ﹤0.01% |
+14,300
| New | +$12.1K |
|
2296
Shattuck Labs
STTK
$710M
| $11.1K | ﹤0.01% |
14,000
-73,100
| -84% | -$70.9K |
|
|
NOTE
2297
DELISTED
FiscalNote
NOTE
| $7.56K | ﹤0.01% |
1,175
+58
| +5% | +$435 |
|
|
ORGN
2298
DELISTED
Origin Materials
ORGN
| $6.09K | ﹤0.01% |
420
-1,207
| -74% | -$20.4K |
|
2299
BioAtla
BCAB
$5.59M
| $5.58K | ﹤0.01% |
282
-3,496
| -93% | -$70.9K |
|
|
ADAP
2300
DELISTED
Adaptimmune Therapeutics
ADAP
| $3.19K | ﹤0.01% |
13,304
-193,428
| -94% | -$51.6K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, Two Sigma Advisers held 2,611 positions worth $48.8B, up 9.9% from $44.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Two Sigma Advisers's Q2 2025 filing shows 251 new, 862 increased, 1,166 reduced and 311 closed positions. Its largest new stake was UnitedHealth: 759,500 shares worth $237M. The largest sale was Broadcom, an estimated $768M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Two Sigma Advisers's largest Q2 2025 buy was UnitedHealth: 759,500 shares worth $237M.
- Two Sigma Advisers added most to T-Mobile US in Q2 2025, an estimated $479M increase.
- Two Sigma Advisers's biggest Q2 2025 reduction was Broadcom, cutting an estimated $768M.
- Two Sigma Advisers fully exited Advanced Micro Devices in Q2 2025, selling an estimated $155M.
- Two Sigma Advisers's ten largest holdings make up 19% of its $48.8B portfolio in Q2 2025.
- Two Sigma Advisers opened 251 new positions and closed 311 in Q2 2025.
- Two Sigma Advisers's portfolio value rose 9.9% quarter-over-quarter to $48.8B.
Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.